Tapewire

Nasdaq · USD

VRTX

VERTEX PHARMACEUTICALS INC / MA

Export transactions ↓
Tapewire entity
2875
SEC CIK
0000875320
Parsed reports
2,554

Last 12 months

Inside the activity.

0 purchase rows · 93 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202506
Dec 2025016
Jan 202602
Feb 2026049
Mar 202605
Apr 202601
May 202606
Jun 202605
Jul 202603
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 01, 2015 Filed Oct 6, 2015 00:15 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 5,159 $104.45 $538,857.55
Disclosure

SEC source: 0001209191-15-074184 · doc4.xml · nonDerivative · entry 3

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,756

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $104.45 (range $103.89 to $104.88).

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:15 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 900 $103.28 $92,952.00
Disclosure

SEC source: 0001209191-15-074184 · doc4.xml · nonDerivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,915

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $103.28 (range $102.71 to $103.60).

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:15 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 700 $102.30 $71,610.00
Disclosure

SEC source: 0001209191-15-074184 · doc4.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 126,815

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $102.30 (range $101.68 to $102.66).

F3 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:16 UTC
Lee YuchunDirector
Exercise / conversionStock Option (right to buy) · Derivative 1,333 $0.00 Strike: $57.27 $0.00
Disclosure

SEC source: 0001209191-15-074185 · doc4.xml · derivative · entry 5

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,334

Underlying: Common Stock · 1,333 shares

Expires 2022-09-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 09/14/2012.

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:16 UTC
Lee YuchunDirector
SaleCommon Stock 225 $105.79 $23,802.75
Disclosure

SEC source: 0001209191-15-074185 · doc4.xml · nonDerivative · entry 4

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416

F1 · shares: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $105.79 (range $105.74 to $105.85).

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:16 UTC
Lee YuchunDirector
SaleCommon Stock 700 $104.79 $73,353.00
Disclosure

SEC source: 0001209191-15-074185 · doc4.xml · nonDerivative · entry 3

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 641

F1 · shares: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $104.79 (range $104.38 to $105.36).

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:16 UTC
Lee YuchunDirector
SaleCommon Stock 200 $102.80 $20,560.00
Disclosure

SEC source: 0001209191-15-074185 · doc4.xml · nonDerivative · entry 2

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,341

F1 · shares: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Open market sales reported on this line occurred at a weighted average price of $102.80 (range $102.66 to $102.94).

F3 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

Read SEC document
October 01, 2015 Filed Oct 6, 2015 00:16 UTC
Lee YuchunDirector
Exercise / conversionCommon Stock 1,333 $57.27 $76,340.91
Disclosure

SEC source: 0001209191-15-074185 · doc4.xml · nonDerivative · entry 1

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,541

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 21:39 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-072818 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 177,600

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
September 30, 2015 Filed Oct 1, 2015 21:39 UTC SaleCommon Stock 400 $105.13 $42,052.00
Disclosure

SEC source: 0001209191-15-072818 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $105.13 (range $105.11 to $105.16).

Read SEC document
September 30, 2015 Filed Oct 1, 2015 21:39 UTC SaleCommon Stock 2,260 $104.15 $235,379.00
Disclosure

SEC source: 0001209191-15-072818 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $104.15 (range $103.76 to $104.75).

Read SEC document
September 30, 2015 Filed Oct 1, 2015 21:39 UTC SaleCommon Stock 4,040 $103.20 $416,928.00
Disclosure

SEC source: 0001209191-15-072818 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,944

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $103.20 (range $102.74 to $103.73).

Read SEC document
September 30, 2015 Filed Oct 1, 2015 21:39 UTC SaleCommon Stock 3,700 $102.24 $378,288.00
Disclosure

SEC source: 0001209191-15-072818 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 351,984

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $102.24 (range $101.74 to $102.72).

Read SEC document
September 30, 2015 Filed Oct 1, 2015 21:39 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-072818 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · derivative · entry 11

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,000

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F10 · derivative.exercise_date: Fully vested.

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 502 $115.34 $57,900.68
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F9 · price: Open market sales reported on this line occurred at a weighted average price of $115.34 (range $115.25 to $115.40).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 1,300 $114.58 $148,954.00
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,786

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F8 · price: Open market sales reported on this line occurred at a weighted average price of $114.58 (range $114.20 to $114.95).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 800 $113.37 $90,696.00
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 6

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,086

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F7 · price: Open market sales reported on this line occurred at a weighted average price of $113.37 (range $113.00 to $113.82).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 1,310 $112.45 $147,309.50
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 347,886

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $112.45 (range $112.00 to $112.86).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 4,288 $111.35 $477,468.80
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 349,196

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $111.35 (range $110.88 to $111.86).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 1,200 $110.23 $132,276.00
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $110.23 (range $109.75 to $110.59).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC SaleCommon Stock 1,000 $109.09 $109,090.00
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,684

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $109.09 (range $108.58 to $109.50).

Read SEC document
September 23, 2015 Filed Sep 24, 2015 19:45 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-072080 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 16, 2015 Filed Sep 18, 2015 12:05 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-071282 · doc4.xml · derivative · entry 7

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 198,400

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: Fully vested.

Read SEC document
September 16, 2015 Filed Sep 18, 2015 12:05 UTC SaleCommon Stock 1,000 $134.09 $134,090.00
Disclosure

SEC source: 0001209191-15-071282 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $134.09 (range $133.90 to $134.37).

Read SEC document
September 16, 2015 Filed Sep 18, 2015 12:05 UTC SaleCommon Stock 2,500 $132.41 $331,025.00
Disclosure

SEC source: 0001209191-15-071282 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 353,184

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $132.41 (range $131.86 to $132.81).

Read SEC document
September 16, 2015 Filed Sep 18, 2015 12:05 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-071282 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2015 Filed Sep 11, 2015 13:10 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-070274 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208,800

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
September 09, 2015 Filed Sep 11, 2015 13:10 UTC SaleCommon Stock 500 $133.41 $66,705.00
Disclosure

SEC source: 0001209191-15-070274 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $133.41 (range $133.08 to $133.75).

Read SEC document
September 09, 2015 Filed Sep 11, 2015 13:10 UTC SaleCommon Stock 1,100 $132.35 $145,585.00
Disclosure

SEC source: 0001209191-15-070274 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,784

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $132.35 (range $132.06 to $132.52).

Read SEC document
September 09, 2015 Filed Sep 11, 2015 13:10 UTC SaleCommon Stock 8,000 $131.29 $1,050,320.00
Disclosure

SEC source: 0001209191-15-070274 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,884

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $131.29 (range $130.79 to $131.78).

Read SEC document
September 09, 2015 Filed Sep 11, 2015 13:10 UTC SaleCommon Stock 800 $130.02 $104,016.00
Disclosure

SEC source: 0001209191-15-070274 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 354,884

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $130.02 (range $129.78 to $130.68).

Read SEC document
September 09, 2015 Filed Sep 11, 2015 13:10 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-070274 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2015 Filed Sep 18, 2015 12:05 UTC SaleCommon Stock 6,900 $133.42 $920,598.00
Disclosure

SEC source: 0001209191-15-071282 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 346,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $133.42 (range $132.89 to $133.81).

Read SEC document
September 04, 2015 Filed Sep 9, 2015 20:28 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionStock Option (right to buy) · Derivative 9,063 $0.00 Strike: $53.74 $0.00
Disclosure

SEC source: 0001209191-15-069921 · doc4.xml · derivative · entry 6

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,125

Underlying: Common Stock · 9,063 shares

Expires 2022-09-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 09/04/2012.

Read SEC document
September 04, 2015 Filed Sep 9, 2015 20:28 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 3,463 $126.44 $437,861.72
Disclosure

SEC source: 0001209191-15-069921 · doc4.xml · nonDerivative · entry 4

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 127,515

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $126.44 (range $126.00 to $126.92).

Read SEC document
September 04, 2015 Filed Sep 9, 2015 20:28 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 5,200 $125.42 $652,184.00
Disclosure

SEC source: 0001209191-15-069921 · doc4.xml · nonDerivative · entry 3

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,978

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $125.42 (range $124.99 to $125.98).

Read SEC document
September 04, 2015 Filed Sep 9, 2015 20:28 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
SaleCommon Stock 400 $124.43 $49,772.00
Disclosure

SEC source: 0001209191-15-069921 · doc4.xml · nonDerivative · entry 2

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,178

F1 · kind: Transaction made pursuant to Mr. Arbuckle's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Arbuckle undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $124.43 (range $123.98 to $124.85).

Read SEC document
September 04, 2015 Filed Sep 9, 2015 20:28 UTC
Arbuckle Stuart AEVP\Chief Commercial Officer
Exercise / conversionCommon Stock 9,063 $53.74 $487,045.62
Disclosure

SEC source: 0001209191-15-069921 · doc4.xml · nonDerivative · entry 1

Arbuckle Stuart A · CIK 0001557290 · EVP\Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,578

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 02, 2015 Filed Sep 3, 2015 21:25 UTC Exercise / conversionStock Option (right to buy) · Derivative 10,400 $0.00 Strike: $35.64 $0.00
Disclosure

SEC source: 0001209191-15-069496 · doc4.xml · derivative · entry 8

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 219,200

Underlying: Common Stock · 10,400 shares

Expires 2016-02-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: Fully vested.

Read SEC document
September 02, 2015 Filed Sep 3, 2015 21:25 UTC SaleCommon Stock 700 $128.06 $89,642.00
Disclosure

SEC source: 0001209191-15-069496 · doc4.xml · nonDerivative · entry 5

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,284

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F6 · price: Open market sales reported on this line occurred at a weighted average price of $128.06 (range $127.66 to $128.29).

Read SEC document
September 02, 2015 Filed Sep 3, 2015 21:25 UTC SaleCommon Stock 2,500 $126.76 $316,900.00
Disclosure

SEC source: 0001209191-15-069496 · doc4.xml · nonDerivative · entry 4

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 345,984

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $126.76 (range $126.43 to $127.23).

Read SEC document
September 02, 2015 Filed Sep 3, 2015 21:25 UTC SaleCommon Stock 3,700 $125.79 $465,423.00
Disclosure

SEC source: 0001209191-15-069496 · doc4.xml · nonDerivative · entry 3

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 348,484

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $125.79 (range $125.37 to $126.32).

Read SEC document
September 02, 2015 Filed Sep 3, 2015 21:25 UTC SaleCommon Stock 3,500 $124.83 $436,905.00
Disclosure

SEC source: 0001209191-15-069496 · doc4.xml · nonDerivative · entry 2

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 352,184

F1 · kind: Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.

F2 · price: Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $124.83 (range $124.22 to $125.21).

Read SEC document
September 02, 2015 Filed Sep 3, 2015 21:25 UTC Exercise / conversionCommon Stock 10,400 $35.64 $370,656.00
Disclosure

SEC source: 0001209191-15-069496 · doc4.xml · nonDerivative · entry 1

BOGER JOSHUA S · CIK 0001197023 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,684

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 01, 2015 Filed Sep 3, 2015 21:24 UTC
Lee YuchunDirector
GrantStock Option · Derivative 1,333 $0.00 Strike: $57.27 $0.00
Disclosure

SEC source: 0001209191-15-069493 · doc4.xml · derivative · entry 5

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,667

Underlying: Common Stock · 1,333 shares

Expires 2022-09-13

F6 · derivative.exercise_date: The option vests in 16 quarterly installments from 9/14/2012.

Read SEC document
September 01, 2015 Filed Sep 3, 2015 21:24 UTC
Lee YuchunDirector
SaleCommon Stock 200 $126.32 $25,264.00
Disclosure

SEC source: 0001209191-15-069493 · doc4.xml · nonDerivative · entry 4

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 208

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F5 · price: Open market sales reported on this line occurred at a weighted average price of $126.32 (range $126.25 to $126.38).

Read SEC document
September 01, 2015 Filed Sep 3, 2015 21:24 UTC
Lee YuchunDirector
SaleCommon Stock 825 $125.35 $103,413.75
Disclosure

SEC source: 0001209191-15-069493 · doc4.xml · nonDerivative · entry 3

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 408

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F4 · price: Open market sales reported on this line occurred at a weighted average price of $125.35 (range $125.01 to $125.81).

Read SEC document
September 01, 2015 Filed Sep 3, 2015 21:24 UTC
Lee YuchunDirector
SaleCommon Stock 100 $123.92 $12,392.00
Disclosure

SEC source: 0001209191-15-069493 · doc4.xml · nonDerivative · entry 2

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,233

F1 · kind: Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.

F2 · price: Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.

F3 · price: Open market sales reported on this line occurred at a weighted average price of $123.92 (range $123.92 to $123.92).

Read SEC document
September 01, 2015 Filed Sep 3, 2015 21:24 UTC
Lee YuchunDirector
Exercise / conversionCommon Stock 1,333 $57.27 $76,340.91
Disclosure

SEC source: 0001209191-15-069493 · doc4.xml · nonDerivative · entry 1

Lee Yuchun · CIK 0001334365 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,333

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.